CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions
In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work
Administration Plans to Stop Paying Advisors; NIH, HHS to Make Protest
Talbot, Schein Ask Weickar for 41.3 Billion for NCI
Neutron Answers Needed Soon, Kligerman Says
DeVita Losing Patience, Responds To Powers Letter
NCI Offers 200 Cell Lines to Scientist
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
